| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/05/2009 | WO2009027514A1 Means and methods for the discrimination of gdf-15 elevation related or unrelated to cardiac disorders |
| 03/05/2009 | WO2009027388A2 Imaging medium comprising hyperpolarised 13c-acetate and use thereof |
| 03/05/2009 | WO2009027339A1 Surfactant proteins b and d in differentiating the causes of shortness of breath |
| 03/05/2009 | WO2009027168A1 Field effect transistor gas sensor having a housing and porous catalytic material contained therein |
| 03/05/2009 | WO2009027106A2 Non-invasive in vivo imaging and methods for treating type i diabetes |
| 03/05/2009 | WO2009026941A1 Genetically encoded calcium sensors comprising the c-terminal lobe of troponin c and a fluorescence tag |
| 03/05/2009 | WO2009026920A1 Compositions and means for diagnosing microbial infections |
| 03/05/2009 | WO2009026867A1 Use of cyanocinnamic acid derivatives as matrices in maldi mass spectrometry |
| 03/05/2009 | WO2009026729A1 Amino acid pairing-based self assembling peptides and methods |
| 03/05/2009 | WO2009026705A1 Method of diagnosing and treating osteoarthritis |
| 03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/05/2009 | WO2009026681A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists |
| 03/05/2009 | WO2009026660A1 Dendritic cell marker and uses thereof |
| 03/05/2009 | WO2009026653A1 Neuroplasticity assay |
| 03/05/2009 | WO2009026622A1 Modulators of hypersensitivity reactions |
| 03/05/2009 | WO2009026605A2 Set of tumour-markers |
| 03/05/2009 | WO2009014987A3 Identification and quantification of biomarkers for evaluating the risk of preterm birth |
| 03/05/2009 | WO2009012384A3 Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1 |
| 03/05/2009 | WO2009012382A3 Compositions, kits, and methods for the modulation of immune responses using galectin-1 |
| 03/05/2009 | WO2009012356A3 Imaging nucleic acid binding proteins |
| 03/05/2009 | WO2009012140A3 Drug selection for lung cancer therapy using antibody-based arrays |
| 03/05/2009 | WO2009009779A3 Automated bone marrow cellularity determination |
| 03/05/2009 | WO2009008942A3 Computational diagnostic methods for identifying organisms and applications thereof |
| 03/05/2009 | WO2009007913A3 Protein labelling with tags comprising isotope-coded sub-tags and isobaric sub-tags |
| 03/05/2009 | WO2009007858A3 Method for detecting and quantifying analytes on a solid support with liposome-encapsulated fluorescent molecules |
| 03/05/2009 | WO2009007649A3 Device and method for identifying and determining blood groups |
| 03/05/2009 | WO2009006323A3 Methods and marker combinations for screening for predisposition to lung cancer |
| 03/05/2009 | WO2009005109A3 Fuel deterioration detection apparatus for internal combustion engine |
| 03/05/2009 | WO2009001135A3 Combinatorial libraries and related methods |
| 03/05/2009 | WO2008157584A3 Apparatus and methods for automatic insertion, debubbling, cleaning and calibration of a spectral probe during dissolution testing |
| 03/05/2009 | WO2008157325A3 Devices, systems, and methods for measuring glucose |
| 03/05/2009 | WO2008153790A3 Methods of modulating inflammation and compositions therefore |
| 03/05/2009 | WO2008151207A3 Expression quantification using mass spectrometry |
| 03/05/2009 | WO2008149365A3 Systems and methods for focusing particles |
| 03/05/2009 | WO2008149088A3 Melanoma assay and antigens |
| 03/05/2009 | WO2008140599A3 Surface-bound fluorinated esters for amine capture |
| 03/05/2009 | WO2008137881A3 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 03/05/2009 | WO2008135274A3 Method for the detection of specific immunoglobulin class g antibodies |
| 03/05/2009 | WO2008074101A3 Artificial selection method and reagents |
| 03/05/2009 | WO2008011430A3 Compositions and methods for the treatment of diseases associated with aberrant cilia assembly and regulation |
| 03/05/2009 | WO2007079250A3 Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
| 03/05/2009 | WO2007002480A3 Systems and methods including self-contained cartridges with detection systems and fluid delivery systems |
| 03/05/2009 | WO2005014618A3 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 03/05/2009 | WO2005003311A9 Enzymes for starch processing |
| 03/05/2009 | WO2003048376A9 Modulation of immune-cell related disorders using il-1hy2 |
| 03/05/2009 | US20090064350 Detection and treatment of drug associated angioedema |
| 03/05/2009 | US20090062543 Uv excitable fluorescent energy transfer dyes |
| 03/05/2009 | US20090062522 Monolithic-shaped bodies for purifying and separating biopolymers |
| 03/05/2009 | US20090062369 Use of secretory phospholipase a2 (spla2) inhibitors to decrease spla2 levels |
| 03/05/2009 | US20090062286 Crystal Structure of SMYD3 Protein |
| 03/05/2009 | US20090062255 Tumor-targeting evaluation methodology and compounds related thereto |
| 03/05/2009 | US20090062226 Method and Compositions for Inhibiting MAGE Protein Interaction With KAP-1 |
| 03/05/2009 | US20090062205 Reconstitution Medium For Protein and Peptide Formulations |
| 03/05/2009 | US20090062194 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/05/2009 | US20090062188 Disease-Associated Protein |
| 03/05/2009 | US20090062183 Modulation of synaptogenesis |
| 03/05/2009 | US20090062179 determining whether a cancer cell is sensitive to endocrine therapy by detecting the presence of binding of Deleted in Breast Cancer-1 (DBC-1) and Estrogen Receptor alpha (ER alpha ) |
| 03/05/2009 | US20090062148 Substrate preparation process |
| 03/05/2009 | US20090062141 Method for evaluating drug candidates |
| 03/05/2009 | US20090062137 Methods For Identification, and Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases |
| 03/05/2009 | US20090062133 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |
| 03/05/2009 | US20090062126 Use of c3 to c14 aliphatic aldehydes, ketones and primary and secondary c3 to c7 aliphatic alcohols to inhibit sprouting of potato tubers |
| 03/05/2009 | US20090061536 Si/Si3N4 SYSTEM NANOSIZED PARTICLES, BIOSUBSTANCE LABELING AGENT EMPLOYING THE NANOSIZED PARTICLES, AND METHOD OF MANUFACTURING THE NANOSIZED PARTICLES |
| 03/05/2009 | US20090061535 Method of adjusting the working range of multi-analyte assay |
| 03/05/2009 | US20090061534 Assay Device with Shared Zones |
| 03/05/2009 | US20090061533 Structure, target substance detection element and target substance detection kit |
| 03/05/2009 | US20090061532 Fluorescence resonance energy transfer detection with nanoparticles for in vitro and in vivo applications |
| 03/05/2009 | US20090061531 Dna binding protein |
| 03/05/2009 | US20090061528 mono- and bis-substituted 8-hydroxypyrene-1,3,6-trisulfonic acid dyes (HPTA) containing pyrene rings; hydrogels; glucose sensors |
| 03/05/2009 | US20090061527 Methods and Devices for Detecting Nucleic Acid Hybridization |
| 03/05/2009 | US20090061526 Nucleic acid sequencing by selective excitation of microparticles |
| 03/05/2009 | US20090061525 On-chip analysis of covalently labelled sample species |
| 03/05/2009 | US20090061524 Enzyme-Channeling Based Electrochemical Biosensors |
| 03/05/2009 | US20090061523 Mass defect labeling and methods of use thereof |
| 03/05/2009 | US20090061522 Automated Protein Analyzer |
| 03/05/2009 | US20090061480 Nucleotide sequence encoding a modulator of nf-kb |
| 03/05/2009 | US20090061475 Methods for Identifying Compounds for the Treatment of Type 1 Diabetes |
| 03/05/2009 | US20090061472 Assessing the risk of a major adverse cardiac event in patients with chest pain |
| 03/05/2009 | US20090061467 Methods and Compositions for Measuring Canine BNP and Uses Thereof |
| 03/05/2009 | US20090061466 Anti-drug antibody assay |
| 03/05/2009 | US20090061465 Composition for analyzing diabetes mellitus and/or retinal vascular disease and analyzing method thereof |
| 03/05/2009 | US20090061464 Methods for detecting and/or quantifying a concentration of specific bacterial molecules using bacterial biosensors |
| 03/05/2009 | US20090061463 P-Selectin associated with Eosinophils as a marker for asthma and correlating with B-1 integrin activation |
| 03/05/2009 | US20090061462 Prion-specific peptide reagents |
| 03/05/2009 | US20090061461 Phosphorylated or Non-Phosphorylated MPR as Diagnostic Marker or Therapeutic Target |
| 03/05/2009 | US20090061460 Test apparatus, production method therefor and test method |
| 03/05/2009 | US20090061459 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 03/05/2009 | US20090061458 Heterooligomeric Taste Receptor |
| 03/05/2009 | US20090061457 Apolipoprotein E3 protein as a biomarker of Parkinson's disease |
| 03/05/2009 | US20090061456 Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells |
| 03/05/2009 | US20090061455 Use of Glycosaminoglycans to Reduce Non-Specific Binding in Immunoassays |
| 03/05/2009 | US20090061453 Methods and compositions for detecting colon cancers |
| 03/05/2009 | US20090061452 Polymorphisms in the human genes for OCT 1 and their use in diagnostic and therapeutic applications |
| 03/05/2009 | US20090061451 Biosensors and related methods |
| 03/05/2009 | US20090061449 Systems and methods for processing hybrid seed |
| 03/05/2009 | US20090061443 Diagnostic and Therapeutic Targets for Leukemia |
| 03/05/2009 | US20090061436 Peptide sequence that promotes tumor invasion |
| 03/05/2009 | US20090061431 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
| 03/05/2009 | US20090061430 Reactive surfaces, substrates and methods of producing and using same |
| 03/05/2009 | US20090061427 Gene Encoding Protein Responsible for Flocculation Property of Yeast and Use Thereof |